Fungal meningitis historical perspective: Difference between revisions
Jump to navigation
Jump to search
Prince Djan (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (18 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{PTD}} | {{CMG}}; {{AE}} {{PTD}} | ||
==Overview== | ==Overview== | ||
The first report of human [[cryptococcosis]] was published by Busse and Busckhe more than 100 years ago; 10 years later, it was identified as the cause of human [[meningitis]]. [[Cryptococcus neoformans]], an encapsulated [[Yeast|basidiomycetous yeast]], represents one of the most common [[Pathogens|CNS pathogens]] encountered in clinical practice today. In 1661, Thomas Willis first described the [[inflammation]] of [[meninges]] and an [[epidemic]] of meningitis. In 1891, Heinrich Quincke provided an early analysis of [[CSF]] by introducing a new technique of [[lumbar puncture]]. Some specific historical feature usually surround the [[outbreak]] of rare causes of [[fungal meningitis]]. For example, outbreaks of fungal meningitis in 2002 with [[Exophiala|Exophiala (Wangiella) dermatitidis]] and more recently in 2012 with Exserohilum rostratum were associated with contamination of compounded [[corticosteroids]] with resultant severe complications.<ref name="pmid12532960" /><ref name="pmid23252499" /><ref name="pmid23465119" /> The 1980s witnessed an increase in the number of cases of [[cryptococcus]] meningitis in the [[United States]] and certain African countries largely due to [[Human Immunodeficiency Virus (HIV)|HIV]] infection | |||
==Historical perspective== | ==Historical perspective== | ||
The major advancements in the history of meningitis may be summarized as follows:<ref name="pmid19892131">{{cite journal| author=Tyler KL| title=Chapter 28: a history of bacterial meningitis. | journal=Handb Clin Neurol | year= 2010 | volume= 95 | issue= | pages= 417-33 | pmid=19892131 | doi=10.1016/S0072-9752(08)02128-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19892131 }} </ref> <ref name=abc> Fungal Meningitis, Infections of the Central Nervous System Author: Horan ; Perfect, Jennifer, John L. R. Identifier: ISBN: 978-1-4698-8366-3 Part VI chapter 40 </ref> | |||
* [[Cryptococcus neoformans]], an encapsulated [[Basidiomycete|basidiomycetous yeast]], represents one of the most common CNS pathogens encountered in clinical practice today. | |||
* The first report of human [[cryptococcosis]] was published by Busse and Busckhe more than 100 years ago; 10 years later, it was identified as the cause of human meningitis. | |||
*In 1661, Thomas Willis first described the [[inflammation]] of [[meninges]] and an [[epidemic]] of [[meningitis]]. | |||
*In 1891, Heinrich Quincke provided an early analysis of [[CSF]] by introducing a new technique of [[lumbar puncture]]. | |||
*In early 19th century, detailed profile of [[CSF]] analysis in meningitis was explained by William Mestrezat, and H. Houston Merritt. | |||
*Advancements regarding the treatment of [[meningitis]] was given by Georg Joachmann in Germany and Simon Flexnor in USA in 18th and 19th century respectively | |||
*Some specific historical feature usually surround the [[outbreak]] of rare causes of fungal meningitis. For example, [[outbreaks]] of fungal meningitis in 2002 with [[Exophiala|Exophiala (Wangiella) dermatitidis]] and more recently in 2012 with Exserohilum rostratum were associated with contamination of compounded [[corticosteroids]] with resultant severe complications.<ref name="pmid12532960">{{cite journal| author=| title=From the Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002. | journal=JAMA | year= 2003 | volume= 289 | issue= 3 | pages= 291-3 | pmid=12532960 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12532960 }} </ref><ref name="pmid23252499">{{cite journal| author=Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, Duwve J et al.| title=Fungal infections associated with contaminated methylprednisolone injections. | journal=N Engl J Med | year= 2013 | volume= 369 | issue= 17 | pages= 1598-609 | pmid=23252499 | doi=10.1056/NEJMoa1213978 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23252499 }} </ref><ref name="pmid23465119">{{cite journal| author=Pettit AC, Pugh ME| title=Index case for the fungal meningitis outbreak, United States. | journal=N Engl J Med | year= 2013 | volume= 368 | issue= 10 | pages= 970 | pmid=23465119 | doi=10.1056/NEJMc1300630 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23465119 }} </ref> | |||
*Between 1960s and 1970s, data from some United States hospitals showed an increase in the [[incidence]] of systemic [[fungal infections]], including [[cryptococcosis]].<ref name="pmid480580">{{cite journal| author=Fraser DW, Ward JI, Ajello L, Plikaytis BD| title=Aspergillosis and other systemic mycoses. The growing problem. | journal=JAMA | year= 1979 | volume= 242 | issue= 15 | pages= 1631-5 | pmid=480580 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=480580 }} </ref> | |||
*The 1980s witnessed an increase in the number of cases of [[cryptococcus]] meningitis in the United States and certain African countries largely due to [[Human Immunodeficiency Virus (HIV)|HIV]] infection. | |||
==References== | |||
{{reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | |||
Latest revision as of 21:47, 29 July 2020
|
Fungal meningitis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Fungal meningitis historical perspective On the Web |
|
American Roentgen Ray Society Images of Fungal meningitis historical perspective |
|
Risk calculators and risk factors for Fungal meningitis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]
Overview
The first report of human cryptococcosis was published by Busse and Busckhe more than 100 years ago; 10 years later, it was identified as the cause of human meningitis. Cryptococcus neoformans, an encapsulated basidiomycetous yeast, represents one of the most common CNS pathogens encountered in clinical practice today. In 1661, Thomas Willis first described the inflammation of meninges and an epidemic of meningitis. In 1891, Heinrich Quincke provided an early analysis of CSF by introducing a new technique of lumbar puncture. Some specific historical feature usually surround the outbreak of rare causes of fungal meningitis. For example, outbreaks of fungal meningitis in 2002 with Exophiala (Wangiella) dermatitidis and more recently in 2012 with Exserohilum rostratum were associated with contamination of compounded corticosteroids with resultant severe complications.[1][2][3] The 1980s witnessed an increase in the number of cases of cryptococcus meningitis in the United States and certain African countries largely due to HIV infection
Historical perspective
The major advancements in the history of meningitis may be summarized as follows:[4] [5]
- Cryptococcus neoformans, an encapsulated basidiomycetous yeast, represents one of the most common CNS pathogens encountered in clinical practice today.
- The first report of human cryptococcosis was published by Busse and Busckhe more than 100 years ago; 10 years later, it was identified as the cause of human meningitis.
- In 1661, Thomas Willis first described the inflammation of meninges and an epidemic of meningitis.
- In 1891, Heinrich Quincke provided an early analysis of CSF by introducing a new technique of lumbar puncture.
- In early 19th century, detailed profile of CSF analysis in meningitis was explained by William Mestrezat, and H. Houston Merritt.
- Advancements regarding the treatment of meningitis was given by Georg Joachmann in Germany and Simon Flexnor in USA in 18th and 19th century respectively
- Some specific historical feature usually surround the outbreak of rare causes of fungal meningitis. For example, outbreaks of fungal meningitis in 2002 with Exophiala (Wangiella) dermatitidis and more recently in 2012 with Exserohilum rostratum were associated with contamination of compounded corticosteroids with resultant severe complications.[1][2][3]
- Between 1960s and 1970s, data from some United States hospitals showed an increase in the incidence of systemic fungal infections, including cryptococcosis.[6]
- The 1980s witnessed an increase in the number of cases of cryptococcus meningitis in the United States and certain African countries largely due to HIV infection.
References
- ↑ 1.0 1.1 "From the Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002". JAMA. 289 (3): 291–3. 2003. PMID 12532960.
- ↑ 2.0 2.1 Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, Duwve J; et al. (2013). "Fungal infections associated with contaminated methylprednisolone injections". N Engl J Med. 369 (17): 1598–609. doi:10.1056/NEJMoa1213978. PMID 23252499.
- ↑ 3.0 3.1 Pettit AC, Pugh ME (2013). "Index case for the fungal meningitis outbreak, United States". N Engl J Med. 368 (10): 970. doi:10.1056/NEJMc1300630. PMID 23465119.
- ↑ Tyler KL (2010). "Chapter 28: a history of bacterial meningitis". Handb Clin Neurol. 95: 417–33. doi:10.1016/S0072-9752(08)02128-3. PMID 19892131.
- ↑ Fungal Meningitis, Infections of the Central Nervous System Author: Horan ; Perfect, Jennifer, John L. R. Identifier: ISBN: 978-1-4698-8366-3 Part VI chapter 40
- ↑ Fraser DW, Ward JI, Ajello L, Plikaytis BD (1979). "Aspergillosis and other systemic mycoses. The growing problem". JAMA. 242 (15): 1631–5. PMID 480580.